(Q70971469)

English

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

scientific article published on 01 December 1995

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

title

Incorporating toxicity considerations into the design of two-stage phase II clinical trials (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

main subject

phase II clinical trial

1 reference

0 references

Bryant J

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

Day R

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

publication date

1 December 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

volume

51

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

page(s)

1372-1383

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

maintained by WikiProject

WikiProject Mathematics

0 references

Identifiers

DOI

10.2307/2533268

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

JSTOR article ID

2533268

0 references

PubMed publication ID

8589229

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8589229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8589229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 October 2019

zbMATH Open document ID

0871.62090

0 references

(Q70971469)

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)